Examines emerging assisted reproductive technologies that will revolutionise the future of human reproduction and their regulation.

This book explores the social, ethical and legal implications of assisted reproductive technologies (ART). Providing a comparative analysis of several European countries, the authors evaluate the varied approaches to the application of ART throughout Europe. From a global perspective, countries take very different approaches to the regulation of ART. Countries apply restrictions to the access criteria for these treatments and/or direct restrictions to the practice of the techniques themselves. To understand these varied approaches to ART practice and regulation, it is necessary to understand the societal and political background from which they emerged. This book therefore consists of case studies from eight European countries which provide insights into the status and development of the regulation of ART in the last 40 years. The country cases from all over Europe and the three comparative chapters provide insights into the diversity of current ART regulation across the continent as well as into similarities, differences and trends in this regulatory area. This book will be of interest to practitioners of ART who are interested in understanding the differences in regulation of ART in Europe, as well as long-term trends in this respect. Given the ethical and legal implications the book explores, it will also be of interest to students or researchers in the fields of social sciences, humanities and law.

Advances in the field of Assisted Reproductive Technology (ART) have been revolutionary. This book focuses on the use of ARTs in the context of families who seek to conceive a matching sibling donor as a source of tissue to treat an existing sick child. Such children have been referred to as 'saviour siblings'. Considering the legal and regulatory frameworks that impact on the accessibility of this technology in Australia and the UK, the work analyses the ethical and moral issues that arise from the use of the technology for this specific purpose. The author claims the only justification for limiting a family's reproductive liberty in this context is where the exercise of reproductive decision-making results in harm to others. It is argued that the harm principle is the underlying feature of legislative action in Western democratic society, and as such, this principle provides the grounds upon which a strong and persuasive argument is made for a less-restrictive regulatory approach in the context of 'saviour siblings'. The book will be of great relevance and interest to academics, researchers, practitioners and policy makers in the fields of law, ethics, philosophy, science and medicine.

Agri-food bio-technology policy and regulation is transitioning from an early period focused on genetic engineering technologies to ‘next-generation’ rules and regulatory processes linked to challenges originating in a wide variety of new technological processes and applications. Can lessons learned from past and current regulatory oversights of agricultural biotechnology – and other high-technology sectors – help us address new and emerging regulatory challenges in the agri-food genetics sector? The expert contributors in this volume discuss the experiences of a wide range of North American, European and Asian countries with high technology regulation to address four key questions related to the past and future development of agri-food genomics regulation across the globe. how unique is agri-food biotechology regulation, and how can it be evaluated using the existing tools of regulatory analysis developed in examinations of other sectors? is a ‘government to governance’ model of regulatory regime development found in many other sectors relevant in this rapidly evolving sphere of activity? is a stages model of regulatory regime development accurate? And, if so, at which stage are we currently positioned in the regulation of agri-food genomics products and technologies? what drives movement between stages in different countries and sectors? In assessing such drivers, what are the key links between sectoral (meso) developments and more general macro and micro developments such as international relations and administrative behaviour? By updating, extending and challenging earlier empirical and theoretical social science perspectives on agricultural bio-technological regulation, this volume helps to inform future policy formulation. It will be of interest to practitioners and students of biotechnology, agriculture, and science and technology policy, and regulatory processes more generally.

This text describes the rapid advances that have revolutionized reproductive medicine due to the result of converging and overlapping developments in reproductive biology, molecular biology and genetics.

The successful achievement of pregnancies following pre-implantation genetic diagnosis (PGD) was first reported in April 1990. The technology is often used for patients who are at substantial risk of conceiving a pregnancy affected by a known genetic disorder, however from this technology other more controversial uses have arisen such as HLA typing to save the life of a sibling, gender selection for social reasons, the prevention of late onset diseases, or the prevention of diseases which may be genetically predisposed to developing such as breast cancer. The technology surrounding PGD is constantly developing, giving rise to new and unexpected consequences that create fresh ethical and legal dilemmas. Featuring internationally recognized experts in the field, this book critically explores the regulation of PGD and the broader legal and ethical issues associated with it. It looks at the regulatory situation in a number of jurisdictions including New Zealand, Australia and the United Kingdom, but it also explores a number of themes of wide significance including a historical consideration of PGD and its part in the creation of the "genetic embryo" as a political tool, the over regulation of PGD and the ethical difficulties in handling additional unexpected medical information yielded by new technologies. This book will be of particular interest to academics and students of law, medicine and ethics.

Approximately 1% of births in the UK were conceived using IVF. At present IVF and embryo research are controlled by the Human Fertilisation and Embryology Authority which was formed by a 1990 Act, since then scientific progress has been rapid and the Department of Health has announced a review of that Act. This extensive inquiry will inform that review. It covers: regulation of assisted reproduction, problems with HFE Act; the operation of the Act; provision of infertility services; review of the Act; legislative and regulatory models. It makes recommendations on issues such as choosing the sex of babies; the need for a separate review of abortion; the regulatory bodies required; and a legislative framework that balances the freedom of the individual with the interests of the state, so that any intervention has a sound ethical base.

Advances in Fertility and Reproductive Medicine, provides the most current scientific information written by recognized authorities at the forefront of research in their specific fields in reproductive medicine and science. This book includes high quality peer reviewed manuscripts of Plenary topics and Trilogy lectures at the 18th World Congress of Fertility and Sterility. The understanding of mechanisms of disease has expanded exponentially with developments in molecular and cellular biology. Similarly, new innovations in assisted reproductive technologies have opened up numerous options for treatment of infertility and improved understanding of the processes involved in gamete interaction and implantation. The increased focus on evidence-based practice has led to a critical review of existing evidence in the areas of therapy, diagnostic assessment, causation and prognosis and has provided the framework for conducting clinical studies and therapeutic trials that have high validity. Contributing authors have submitted high quality, timely manuscripts, which have allowed this comprehensive text on a wide range of topics in reproductive medicine and science. Advances in Fertility and Reproductive Medicine will provide a very useful resource to research and health care practitioners dedicated to improving the understanding and management of disorders in reproduction.

These essays explore the nature and limits of individual autonomy in law, policy and the work of regulatory agencies. Authors ask searching questions about the nature and scope of the regulation of 'private' lives, from intimacies, personal relationships and domestic lives to reproduction. They question the extent to which the law does, or should, protect individual autonomy. Recent rapid advances in the development of new technologies - particularly those concerned with human genetics and assisted reproduction - have generated new questions (practical, social, legal and ethical) about how far the state should intervene in individual decision making. Is there an inevitable tension between individual liberty and the common good? How might a workable balance between the public and the private be struck? How, indeed, should we think about 'autonomy'? The essays explore the arguments used to create and maintain the boundaries of autonomy - for example, the protection of the vulnerable, public goods of various kinds, and the maintenance of tradition and respect for cultural practices. Contributors address how those boundaries should be drawn and interventions justified. How are contemporary ethical debates about autonomy constructed, and what principles do they embody? What happens when those principles become manifest in law?